glp-1 bacteria A surprising role for enteroendocrine cells and in regulating intestinal inflammation Your gut already produces GLP-1

Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A phase III, randomized, double-blind, placebo-controlled, parallel study

McGlory C, van Vliet S, Stokes T, Mittendorfer B, Phillips SM

Future systematic reviews will be needed once larger, higher-quality studies become available

Ozempic, Mounjaro, and Rybelsus have been covered under Medicare Part D when prescribed for diabetes

Current research (such as studies indexed in PubMed regarding Short-Chain Fatty Acids and Incretin Secretion ) highlights that when gut bacteria ferment these specific fibers, they produce metabolites like butyrate and propionate

Update, June 2025: A group of 21 plaintiffs who suffered NAION after taking the medications asked the state court to consolidate their cases against Novo Nordisk into a multicounty litigation in the State of New Jersey